TITLE

Tay-Sachs Disease

AUTHOR(S)
Cumings, J. N.
PUB. DATE
May 1965
SOURCE
British Medical Journal;5/22/1965, Vol. 1 Issue 5446, p1368
SOURCE TYPE
Review
DOC. TYPE
Book Review
ABSTRACT
No abstract available.
ACCESSION #
64058836

 

Related Articles

  • Tay--Sachs' Disease (Book). Anderson, Ingram F. // Annals of Internal Medicine;May65, Vol. 62 Issue 5, p1104 

    Reviews the book 'Tay-Sachs' Disease,' edited by Bruno M. Volk.

  • Screening for Tay-Sachs disease.  // American Family Physician;2/15/1996, Vol. 53 Issue 3, p991 

    Presents the American College of Obstetricians and Gynecologists' committee opinion on screening for Tay-Sachs disease. Pathophysiology of Tay-Sachs disease; Contact information.

  • GM2 gangliosidosis in British Jacob sheep. Wessels, Mark; Carty, Helen; Baird, Pauline; Beggs, Norman; Cox, Timothy; Cachón, Begoña; Wang, Susan; Davies, Ian; Holmes, Paul; Mackintosh, Adrienne; Chianini, Francesca // Veterinary Record: Journal of the British Veterinary Association;1/4/2014, Vol. 174 Issue 1, p20 

    A letter to the editor is presented on Tay-Sachs disease, a prototypical lysosomal storage disease, in British Jacob sheep.

  • Sandhoff's disease.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2068 

    A definition of the term "Sandhoff's disease," which refers to a rare form of Tay-Sachs disease in which two essential enzymes for metabolizing gangliosides are absent, is presented.

  • Tay-Sachs disease.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2279 

    An encyclopedia entry for "Tay-Sachs disease," which refers to a lipid storage disease named after physicians Warren Tay and Bernard Sachs, is presented.

  • Therapeutic Options for Tay-Sachs Disease. Tandon, Adesh // Einstein Quarterly: Journal of Biology & Medicine;2002, Vol. 19 Issue 1, p10 

    Tay-Sachs disease is a lysosomal storage disease that currently has no effective treatment. This review focuses on novel therapeutic options for Tay-Sachs disease.The methods of therapy discussed are enzyme replacement therapy and substrate deprivation therapy. In addition, the potential...

  • Halakhic Implications for the Screening and Treatment of Jewish Genetic Diseases. Hoffman, Jodi D.; Shanske, Alan // Einstein Quarterly: Journal of Biology & Medicine;1999, Vol. 16 Issue 1, p44 

    Discusses the halakhic approach to some of the problems involved in screening and treatment of Jewish genetic disorders. Problems involved in screening for Tay Sachs; Termination of a fetus with Tay Sachs disease; Practice of organ transplantation in treating Gaucher's disease; Use of gene...

  • Snapshots.  // Baltimore Jewish Times;9/4/2015, Vol. 346 Issue 1, p46 

    A photograph of children getting tested for Tay-Sachs disease at the Baltimore Jewish Community Center (JCC) in Baltimore, Maryland in 1977 is presented.

  • How to Detect A Faulty Gene.  // Time;9/12/1969, Vol. 94 Issue 11, p59 

    The article focuses on the TAY-Sachs disease, a genetic defect in children that leaves them blind, deaf and paralyzed at the age of two. It relates on research by neuroscientists Shintaro Okada and John O'Brien, who found that the missing enzyme in TAY-Sachs patients called hexosaminidase was...

  • Sialidase-mediated depletion of G[sub m2] ganglioside in Tay-Sachs neuroglia cells. Igdoura, Suleiman A.; Mertineit, Carmen; Trasler, Jacquetta M.; Gravel, Roy A. // Human Molecular Genetics;Jun99, Vol. 8 Issue 6, p1111 

    Tay-Sachs disease is a severe, inherited disease of the nervous system caused by accumulation of the brain lipid G[sub M2] ganglioside. Mouse models of Tay-Sachs disease have revealed a metabolic bypass of the genetic defect based on the more potent activity of the enzyme sialidase towards G[sub...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics